当前位置: 首页 > 医疗版 > 疾病专题 > 内分泌科 > 下丘脑-垂体疾病 > 骨质疏松症
编号:13521084
补肾壮骨汤治疗老年性骨质疏松症的疗效及对睡眠质量的影响(1)
http://www.100md.com 2020年1月1日 《世界睡眠医学杂志》 20201
     摘要 目的:討论分析补肾壮骨汤对老年性骨质疏松症的疗效以及对患者睡眠质量的影响。方法:选取2018年10月至2019年10月湖南中医药大学第一附属医院收治的老年骨质疏松患者56例作为研究对象,按照双盲法随机分为观察组和对照组,每组28例。对照组给与常规西药治疗,观察组在对照组治疗的基础上加服补肾壮骨汤进行治疗,比较2组临床疗效以及睡眠质量(PSQI)评分。结果:治疗后,观察组治疗有效率优于对照组,差异有统计学意义(P<0.05);观察组PSQI睡眠指标优于对照组,差异有统计学意义(P<0.05)。结论:对老年骨质疏松患者采用补肾壮骨汤治疗方法,可以有效的缓解患者的临床症状,改善患者睡眠状况,值得临床推广应用。

    关键词 补肾壮骨汤;骨质疏松;老年;睡眠质量

    Effect of Bushen zhuanggu Decoction on Senile Osteoporosis and its Effect on Sleep Quality

    WANG Ziyi1,ZOU Xiaoling2

    (1 Hunan University of Traditional Chinese Medicine,Changsha 410006,China; 2 the First Affiliated Hospital of Hunan university of Traditional Chinese Medicine,Changsha 410007,China)

    Abstract Objective:To discuss and analyze the effect of bushen zhuanggu decoction on senile osteoporosis and its effect on sleep quality.Methods:Selecting the first affiliated hospital of hunan university of Chinese medicine in October 2018,October 2019,56 patients with senile osteoporosis,according to the double-blind randomized divided into two groups,control group(n=28)and observation group(n=28),control group patients give the conventional western medicine treatment,on the basis of the observation group patients take a kidney strong bone soup treatment,compared two groups of patients with clinical efficacy and quality of sleep(PSQI)score.Results:After treatment,the observation group was better than the control group in lower extremity pain,lower back pain,lower extremity flaccidity,lumbar and knee tenderness,and blinding score,the difference was statistically significant(P<0.05).The PSQI sleep index of the observation group was better than that of the control group,and the difference was statistically significant(P<0.05).Conclusion:The application of tonifying the kidney and strengthening the bone decoction to the elderly patients with osteoporosis can effectively relieve the clinical symptoms of the patients and improve the sleep status of the patients,which is worthy of clinical promotion and application., 百拇医药(王梓仪 邹晓玲)
1 2下一页


    参见:首页 > 医疗版 > 疾病专题 > 内分泌科 > 下丘脑-垂体疾病 > 骨质疏松症